Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical utility of functional testing in fibroblasts to diagnose primary mitochondrial disease.

medRxiv : the preprint server for health sciences·2026
Same author

Disease burden of untreated thymidine kinase 2 deficiency: insights from a large patient dataset.

Brain communications·2026
Same author

Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.

Brain communications·2026
Same author

Enrichment of Rare Mitochondrial DNA Variants Among Individuals With Kidney Disease Reveals Undiagnosed Mitochondrial Disease.

Kidney international reports·2026
Same author

Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

European journal of neurology·2026
Same author

4,5-dihydroxyhexanoic acid is a robust circulating and urine marker of mitochondrial disease and its severity.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 13, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

A diagnostic algorithm for metabolic myopathies.

Andres Berardo1, Salvatore DiMauro, Michio Hirano

  • 1Department of Neurology, Columbia University Medical Center, 630 West 168th Street, P&S 4-423, New York, NY 10032, USA.

Current Neurology and Neuroscience Reports
|April 29, 2010
PubMed
Summary
This summary is machine-generated.

Metabolic myopathies are diverse genetic disorders affecting cellular energy production. Recognizing distinct clinical signs is key for diagnosing these conditions, which range from infantile to adult onset.

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: Jun 13, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Metabolic myopathies are a diverse group of disorders stemming from defects in cellular energy metabolism.
  • These defects disrupt the generation of adenosine triphosphate (ATP), primarily impacting mitochondrial oxidative phosphorylation.
  • Key categories include glycogen storage diseases, fatty acid oxidation defects, and mitochondrial disorders affecting the respiratory chain.

Purpose of the Study:

  • To review the general clinical aspects of metabolic myopathies.
  • To highlight diagnostic approaches for common subtypes of metabolic myopathies.
  • To emphasize the importance of recognizing distinct clinical manifestations for accurate diagnosis.

Main Methods:

  • Review of general clinical features of metabolic myopathies.
  • Discussion of diagnostic challenges due to overlapping symptoms like myoglobinuria and exercise intolerance.
  • Presentation of a clinical algorithm for suspected metabolic myopathies in patients with exercise intolerance.

Main Results:

  • Metabolic myopathies present a wide clinical spectrum, from severe infantile multisystemic diseases to adult-onset isolated myopathies.
  • Common symptoms like recurrent myoglobinuria and exercise intolerance can make diagnosis challenging.
  • Distinct clinical manifestations are crucial for guiding diagnostic testing and achieving correct diagnoses.

Conclusions:

  • Accurate diagnosis of metabolic myopathies relies on recognizing specific clinical presentations.
  • Understanding the diverse causes, including glycogen storage diseases, fatty acid oxidation defects, and mitochondrial disorders, is essential.
  • A systematic diagnostic approach is necessary to differentiate and manage these complex conditions.